ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1,

K W Wood1, C Sarnecki, T M Roberts

  • 1Program in Cell and Developmental Biology, Harvard University, Boston, Massachusetts.

Cell
|March 20, 1992
PubMed

Insights

Ras proteins (p21c-ras) are crucial for cell growth, but their signaling pathways were unclear. This study shows ras mediates nerve growth factor and protein kinase C effects on MAP kinases, RSKs, and Raf-1.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Oncogenesis

Background:

  • p21c-ras is vital for tyrosine kinase-stimulated cell growth and differentiation.
  • The specific signaling pathways utilized by p21c-ras remain largely unknown.
  • Understanding these pathways is key to deciphering cellular responses to growth factors.

Purpose of the Study:

  • To elucidate the downstream signaling pathways propagated by p21c-ras.
  • To investigate the role of ras in modulating MAP kinases, RSKs, and Raf-1.
  • To determine how growth factors and phorbol esters activate these signaling molecules via ras.

Main Methods:

  • Utilized a dominant inhibitory mutant of ras (c-Ha-ras(Asn-17)) in PC12 cells.
  • Assessed the activation of MAP kinases (ERK family), RSKs, and Raf-1.
  • Compared signaling in cells expressing the dominant inhibitory mutant versus those expressing an activated ras oncogene.

Main Results:

  • Expression of c-Ha-ras(Asn-17) inhibited growth factor- and phorbol ester-induced activation of MAP kinases, RSKs, and Raf-1 kinase(s).
  • Conversely, expression of an activated ras oncogene was sufficient to stimulate these signaling events.
  • These findings pinpoint ras as a central mediator in these signaling cascades.

Conclusions:

  • Ras proteins are critical mediators of signaling from nerve growth factor receptors and protein kinase C.
  • Ras influences the activation of MAP kinases, RSKs, and Raf-1.
  • This study provides a clearer understanding of ras-mediated cellular growth and differentiation pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...